NIM
NVO

Nicollet Investment Management’s Novo Nordisk NVO Stock Holding History

Nicollet Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Sell
38,896
-309
-0.8% -$13.3K 0.58% 45
2026
Q1 		$1.44M Buy
39,205
+18,633
+91% +$883K 0.49% 49
2025
Q4 		$1.05M Sell
20,572
-18,141
-47% -$928K 0.33% 53
2025
Q3 		$2.15M Sell
38,713
-1,125
-3% -$65.9K 0.7% 37
2025
Q2 		$2.75M Sell
39,838
-2,124
-5% -$144K 0.92% 32
2025
Q1 		$2.91M Buy
41,962
+1,341
+3% +$111K 1.02% 34
2024
Q4 		$3.49M Sell
40,621
-632
-2% -$68.3K 1.2% 29
2024
Q3 		$4.91M Buy
41,253
+58
+0.1% +$7.74K 1.7% 22
2024
Q2 		$5.88M Sell
41,195
-571
-1% -$75.7K 2.2% 13
2024
Q1 		$5.36M Buy
41,766
+76
+0.2% +$9.05K 1.98% 17
2023
Q4 		$4.31M Sell
41,690
-284
-0.7% -$28.1K 1.76% 21
2023
Q3 		$3.82M Buy
41,974
+396
+1% +$34.9K 1.71% 20
2023
Q2 		$3.36M Buy
+41,578
New +$3.4M 1.5% 24

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Nicollet Investment Management's NVO Position: Q2 2026 in Review

Nicollet Investment Management reduced its Novo Nordisk (NVO) stake by 0.79% in Q2 2026, selling an estimated $13.3K and leaving 38,896 shares worth $1.86M. The position accounts for 0.58% of the portfolio, ranked #45.

Nicollet Investment Management first reported a position in NVO in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.88M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Nicollet Investment Management held 38,896 shares of Novo Nordisk worth $1.86M as of Q2 2026.
  • Nicollet Investment Management sold 309 Novo Nordisk shares in Q2 2026, an estimated $13.3K.
  • Novo Nordisk made up 0.58% of Nicollet Investment Management's portfolio in Q2 2026, its #45 holding.
  • Nicollet Investment Management first reported a position in Novo Nordisk in Q2 2023 and has held it in 13 quarters since.
  • Nicollet Investment Management's Novo Nordisk position peaked at $5.88M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Nicollet Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.